Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Apixaban vs. Warfarin in cerebral venous thrombosis
IRCT20240217061039N1Phase 4Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in cerebral sinovenous thrombosis (CSVT) comparing Apixaban with Warfarin (2 arms). Started Apr 2024; status: completed.
02
Drugs
apixabanwarfarin
03
Conditions
cerebral sinovenous thrombosis (CSVT)
Beyond the preview
Go deeper on IRCT20240217061039N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240217061039N1.